Similarly, mutations of the essential non-catalytic subunit of Polε, POLE2, have been associated with a severe combined immunodeficiency with facial dysmorphism and impaired growth (Frugoni et al., 2016). This evidence concerns the gene POLE2 and immune system disorder.